These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27530054)

  • 1. Costs of Diagnostic Assessment for Lung Cancer: A Medicare Claims Analysis.
    Lokhandwala T; Bittoni MA; Dann RA; D'Souza AO; Johnson M; Nagy RJ; Lanman RB; Merritt RE; Carbone DP
    Clin Lung Cancer; 2017 Jan; 18(1):e27-e34. PubMed ID: 27530054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Projected Clinical, Resource Use, and Fiscal Impacts of Implementing Low-Dose Computed Tomography Lung Cancer Screening in Medicare.
    Roth JA; Sullivan SD; Goulart BH; Ravelo A; Sanderson JC; Ramsey SD
    J Oncol Pract; 2015 Jul; 11(4):267-72. PubMed ID: 25943596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-cost imaging in elderly patients with stage IV cancer.
    Hu YY; Kwok AC; Jiang W; Taback N; Loggers ET; Ting GV; Lipsitz SR; Weeks JC; Greenberg CC
    J Natl Cancer Inst; 2012 Aug; 104(15):1164-72. PubMed ID: 22851271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
    Guldbrandt LM
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET/CT and lung cancer: value of fourth and subsequent posttherapy follow-up scans for patient management.
    Marcus C; Paidpally V; Antoniou A; Zaheer A; Wahl RL; Subramaniam RM
    J Nucl Med; 2015 Feb; 56(2):204-8. PubMed ID: 25613535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redistribution of health care costs after the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2005.
    Dinan MA; Curtis LH; Carpenter WR; Biddle AK; Abernethy AP; Patz EF; Schulman KA; Weinberger M
    J Thorac Oncol; 2014 Apr; 9(4):512-8. PubMed ID: 24736074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An economic analysis of sublobar resection versus thermal ablation for early-stage non-small-cell lung cancer.
    Kwan SW; Mortell KE; Hippe DS; Brunner MC
    J Vasc Interv Radiol; 2014 Oct; 25(10):1558-64; quiz 1565. PubMed ID: 25130308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancer.
    Schreyögg J; Weller J; Stargardt T; Herrmann K; Bluemel C; Dechow T; Glatting G; Krause BJ; Mottaghy F; Reske SN; Buck AK
    J Nucl Med; 2010 Nov; 51(11):1668-75. PubMed ID: 21051648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-minimization analysis of alternative diagnostic approaches in a modeled patient with non-small cell lung cancer and subcarinal lymphadenopathy.
    Harewood GC; Wiersema MJ; Edell ES; Liebow M
    Mayo Clin Proc; 2002 Feb; 77(2):155-64. PubMed ID: 11838649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of CT screening in the National Lung Screening Trial.
    Black WC; Gareen IF; Soneji SS; Sicks JD; Keeler EB; Aberle DR; Naeim A; Church TR; Silvestri GA; Gorelick J; Gatsonis C;
    N Engl J Med; 2014 Nov; 371(19):1793-802. PubMed ID: 25372087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point: Should lung cancer screening by chest CT scan be a covered benefit? Yes.
    Yankelevitz DF
    Chest; 2015 Feb; 147(2):287-289. PubMed ID: 25412275
    [No Abstract]   [Full Text] [Related]  

  • 12. 18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation.
    van Loon J; Grutters JP; Wanders R; Boersma L; Dingemans AM; Bootsma G; Geraedts W; Pitz C; Simons J; Brans B; Snoep G; Hochstenbag M; Lambin P; De Ruysscher D
    Eur J Cancer; 2010 Jan; 46(1):110-9. PubMed ID: 19944595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complication Rates and Downstream Medical Costs Associated With Invasive Diagnostic Procedures for Lung Abnormalities in the Community Setting.
    Huo J; Xu Y; Sheu T; Volk RJ; Shih YT
    JAMA Intern Med; 2019 Mar; 179(3):324-332. PubMed ID: 30640382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of chest computed tomography after lung cancer resection: a decision analysis model.
    Kent MS; Korn P; Port JL; Lee PC; Altorki NK; Korst RJ
    Ann Thorac Surg; 2005 Oct; 80(4):1215-22; discussion 1222-3. PubMed ID: 16181843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs for 5-year lung cancer survivors in a tertiary care hospital in South Korea.
    Park YS; Kim SH; Park SK; Park BJ; Kim YT; Lee SM; Yim JJ; Yoo CG; Kim YW; Han SK; Shim YS; Yang SC
    Lung Cancer; 2010 May; 68(2):299-304. PubMed ID: 19646776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timeliness of Recommended Follow-Up After an Abnormal Finding on Diagnostic Chest CT in Smokers at High Risk of Developing Lung Cancer.
    Percac-Lima S; Ashburner JM; Shepard JA; Lennes IT; Rimmelin DE; Atlas SJ
    J Am Coll Radiol; 2016 May; 13(5):497-504. PubMed ID: 26924163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost of illness associated with metastatic breast cancer.
    Rao S; Kubisiak J; Gilden D
    Breast Cancer Res Treat; 2004 Jan; 83(1):25-32. PubMed ID: 14997052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can lung cancer screening by computed tomography be effective in areas with endemic histoplasmosis?
    Starnes SL; Reed MF; Meyer CA; Shipley RT; Jazieh AR; Pina EM; Redmond K; Huffman LC; Pandalai PK; Howington JA
    J Thorac Cardiovasc Surg; 2011 Mar; 141(3):688-93. PubMed ID: 20933243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gaps in Guideline-Concordant Use of Diagnostic Tests Among Lung Cancer Patients.
    Flanagan MR; Varghese TK; Backhus LM; Wood DE; Mulligan MS; Cheng AM; Flum DR; Farjah F
    Ann Thorac Surg; 2015 Dec; 100(6):2006-12. PubMed ID: 26507425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer costs by treatment strategy and phase of care among patients enrolled in Medicare.
    Sheehan DF; Criss SD; Chen Y; Eckel A; Palazzo L; Tramontano AC; Hur C; Cipriano LE; Kong CY
    Cancer Med; 2019 Jan; 8(1):94-103. PubMed ID: 30575329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.